BONIFAZI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 3.430
EU - Europa 1.435
AS - Asia 1.164
SA - Sud America 122
AF - Africa 47
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 11
Totale 6.240
Nazione #
US - Stati Uniti d'America 3.333
CN - Cina 435
SG - Singapore 353
RU - Federazione Russa 327
IT - Italia 320
DE - Germania 279
VN - Vietnam 131
BR - Brasile 100
GB - Regno Unito 86
HK - Hong Kong 84
SE - Svezia 81
CA - Canada 72
UA - Ucraina 72
FR - Francia 67
FI - Finlandia 64
IN - India 38
ZA - Sudafrica 33
TR - Turchia 32
AU - Australia 30
PL - Polonia 28
KR - Corea 26
IE - Irlanda 22
CZ - Repubblica Ceca 20
BE - Belgio 19
JP - Giappone 19
ES - Italia 14
MX - Messico 14
HR - Croazia 12
NL - Olanda 11
EU - Europa 10
IQ - Iraq 9
AR - Argentina 8
BD - Bangladesh 8
PK - Pakistan 8
EC - Ecuador 6
IR - Iran 6
AE - Emirati Arabi Uniti 5
KE - Kenya 4
CL - Cile 3
EG - Egitto 3
AL - Albania 2
AT - Austria 2
AZ - Azerbaigian 2
CR - Costa Rica 2
DZ - Algeria 2
HN - Honduras 2
IS - Islanda 2
LT - Lituania 2
MA - Marocco 2
PA - Panama 2
SN - Senegal 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
DO - Repubblica Dominicana 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 6.240
Città #
Dallas 502
Fairfield 282
Ashburn 279
Singapore 212
Woodbridge 180
Jacksonville 170
Houston 156
San Jose 149
Chandler 126
Ann Arbor 123
Seattle 100
Wilmington 97
Cambridge 95
Hong Kong 79
Boardman 77
Beijing 69
Camerino 64
Los Angeles 59
Dearborn 56
Nanjing 54
Ho Chi Minh City 50
New York 50
Toronto 46
Orem 43
Council Bluffs 41
Munich 39
Hanoi 35
Helsinki 30
Johannesburg 30
San Mateo 26
Moscow 25
Istanbul 24
Milan 24
Seoul 24
Tongling 24
Nanchang 23
Dublin 22
Lauterbourg 22
Lawrence 22
Princeton 22
Santa Clara 21
The Dalles 20
Buffalo 19
Shanghai 19
Brno 17
Brussels 17
London 17
Turku 17
Kraków 16
Kunming 16
Columbus 15
Jinan 15
Ogden 15
Sydney 15
St Louis 14
Tokyo 14
Düsseldorf 13
Redwood City 13
Manchester 12
Rome 12
Shenyang 12
Chennai 11
Frankfurt am Main 11
Jiaxing 11
Morgantown 11
Poplar 11
Stockholm 11
Warsaw 11
Brooklyn 10
Melbourne 10
Monmouth Junction 10
Philadelphia 10
Hebei 9
Hefei 9
Lachine 9
Mumbai 9
Ningbo 9
Ascoli Piceno 8
Changsha 8
Montreal 8
Nürnberg 8
San Diego 8
São Paulo 8
Chicago 7
Nantong 7
Nuremberg 7
Amsterdam 6
Augusta 6
Centro 6
Guangzhou 6
Islamabad 6
Perugia 6
Phoenix 6
Tianjin 6
Tulsa 6
Ankara 5
Atlanta 5
Barcelona 5
Da Nang 5
Denver 5
Totale 4.190
Nome #
1,4-Dioxane nucleus as a suitable scaffold in the building of ligands interacting with NMDA and σ1 receptors 645
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 622
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 327
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 304
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 299
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 254
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 250
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 247
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 241
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 226
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 218
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 217
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 216
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 205
Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1‑[3- (4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77- LH-28-1) 193
Molecular and Stereochemical Requirements of 1,4-Dioxane Ligands for the Interaction with Different Receptor Systems 193
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 186
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 184
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 183
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 181
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 176
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 166
null 129
New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma 129
Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma 125
Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation. 118
New potent muscarinic receptor ligands bearing the 1,4-dioxane nucleus: Investigation on the nature of the substituent in position 2 99
Totale 6.333
Categoria #
all - tutte 21.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.432


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 0 0 38
2021/2022302 38 78 3 15 23 10 10 17 25 41 10 32
2022/2023365 46 18 32 39 42 36 4 19 59 17 36 17
2023/2024282 27 16 27 10 13 28 19 10 25 8 5 94
2024/20251.027 51 7 84 42 25 64 136 215 89 61 88 165
2025/20262.138 103 153 536 280 191 112 218 126 99 170 140 10
Totale 6.333